SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RAPP

Rapport Therapeutics, Inc. (NASDAQ:RAPP)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
25.33-0.60 (-2.31%)
 
Market cap
$1.22B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 7, 2024
Insider Score
/ 100
RAPP Insider Score

Rapport Therapeutics, Inc. has a live Insider Score.

Scored on 6 qualifying trades from 5 insiders in the last 90 days.

Unlock the score

RAPP analyst forecast

RAPP analyst consensus

Moderate Buy5 ratings
Buy 5 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

RAPP 12-month price target

$69.67+175.1% upsideaverage of 3 firms
$89.00High
$50.00Low

Best analysts covering RAPP

  • HC Wainwright & Co.100%success rate · 1 call

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

RAPP analyst ratings

FirmPrice targetAction
GuggenheimBuy$70.00+138.3%Reiterated2026-10-21
—Jones TradingBuy——Reiterated2026-10-21
Wells FargoOverweight$50.00+70.2%Reiterated2026-10-21
—HC Wainwright & Co.Buy——Reiterated2026-10-20
BTIGBuy$89.00+198.8%Reiterated2026-10-20
BTIGBuy$75.00+75.7%Reiterated2026-09-16
—BTIGBuy——Reiterated2026-08-19
—HC Wainwright & Co.Buy——Reiterated2026-08-12
—BTIGBuy——Reiterated2026-08-05
—BTIGBuy——Reiterated2026-07-16
—BTIGBuy——Reiterated2026-05-21
—BTIGBuy——Reiterated2026-05-08
—BTIGBuy——Reiterated2026-04-22
—BTIGBuy——Reiterated2026-03-11
—Wells FargoOverweight——Reiterated2026-03-11
—HC Wainwright & Co.Buy——Reiterated2025-12-09
—BTIGBuy——Reiterated2025-12-08
—CitizensMarket Outperform——Reiterated2025-11-07
—HC Wainwright & Co.Buy——Reiterated2025-09-08
—JMP SecuritiesMarket Outperform——Reiterated2025-07-08

RAPP earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-10-0.65-0.72$0$0
2026-05-07-0.56-0.42$7.5M$20.0M
2026-08-05-0.96-1.19$2.2M$0
2026-11-05-1.200.00$0$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.